نتائج البحث - "David, Vicente"

1

Five-Year Survival Outcomes From the PACIFIC Trial

المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

المصدر: Spigel, D R, Faivre-Finn, C, Gray, J E, Vicente, D, Planchard, D, Paz-Ares, L, Vansteenkiste, J F, Garassino, M C, Hui, R, Quantin, X, Rimner, A, Wu, Y-L, Özgüroğlu, M, Lee, K H, Kato, T, de Wit, M, Kurata, T, Reck, M, Cho, B C, Senan, S, Naidoo, J, Mann, H, Newton, M, Thiyagarajah, P & Antonia, S J 2022, ' Five-Year Survival Outcomes From the PACIFIC Trial : Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, no. 12, pp. 1301-1311 . https://doi.org/10.1200/JCO.21.01308Test
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(12), 1301-1311. American Society of Clinical Oncology
Spigel, D R, Faivre-Finn, C, Gray, J E, Vicente, D, Planchard, D, Paz-Ares, L, Vansteenkiste, J F, Garassino, M C, Hui, R, Quantin, X, Rimner, A, Wu, Y-L, Özgüroğlu, M, Lee, K H, Kato, T, Wit, M D, Kurata, T, Reck, M, Cho, B C, Senan, S, Naidoo, J, Mann, H, Newton, M, Thiyagarajah, P & Antonia, S J 2022, ' Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer ', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.21.01308Test

مصطلحات موضوعية: Cancer Research, Lung Neoplasms, Manchester Cancer Research Centre, Oncology, ResearchInstitutes_Networks_Beacons/mcrc, Carcinoma, Non-Small-Cell Lung, Disease Progression, Antibodies, Monoclonal, Humans, Chemoradiotherapy

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d7eafbcbb57f61fad4fd50892336d30Test
https://doi.org/10.1200/jco.21.01308Test

2

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

المؤلفون: Silvia Novello, Dariusz M. Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente, Julien Mazières, Jeronimo Rodríguez-Cid, Ali Tafreshi, Ying Cheng, Ki Hyeong Lee, Alexander Golf, Shunichi Sugawara, Andrew G. Robinson, Balazs Halmos, Erin Jensen, Paul Schwarzenberger, M. Catherine Pietanza, Luis Paz-Ares

مصطلحات موضوعية: Pembrolizumab Plus Chemotherapy, Squamous Non-Small-Cell Lung Cancer, Phase III, KEYNOTE-407 Study, Cancer Research, KEYNOTE-407 Study, Phase III, Oncology, Squamous Non-Small-Cell Lung Cancer, Pembrolizumab Plus Chemotherapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3758a1a00f33c4be9c5aa10c3a18bc9cTest
https://hdl.handle.net/2318/1890591Test

3

Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis

المؤلفون: Ute Jungwirth, Liam Jenkins, Marjan Iravani, Qiong Gao, Syed Haider, Clare M. Isacke, Rachel J Evans, David Vicente, Antoinette van Weverwijk, John Alexander

المصدر: Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Nature Communications

مصطلحات موضوعية: 0301 basic medicine, General Physics and Astronomy, Metastasis, Mice, 0302 clinical medicine, Breast cancer, Cancer-Associated Fibroblasts, Tumor Microenvironment, Neoplasm Metastasis, Cells, Cultured, Tumor Stem Cell Assay, Mice, Knockout, education.field_of_study, Mice, Inbred BALB C, Multidisciplinary, Membrane Glycoproteins, Phenotype, Extracellular Matrix, Mechanisms of disease, 030220 oncology & carcinogenesis, Female, Cancer microenvironment, Stromal cell, Cell Survival, Science, Population, Breast Neoplasms, Receptors, Cell Surface, Biology, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, Stroma, Spheroids, Cellular, medicine, Animals, Humans, education, Cell Proliferation, Tumor microenvironment, Genetic heterogeneity, General Chemistry, medicine.disease, Coculture Techniques, 030104 developmental biology, Cancer research, NIH 3T3 Cells, Stromal Cells

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7f7ad032de19c6785c351ff1c5039aTest
https://doaj.org/article/d33b1b683b5f48278db9816c890eda30Test

4

Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer

المؤلفون: Davey B. Daniel, Luis Paz-Ares, Mustafa Ozguroglu, Corinne Faivre-Finn, Scott J. Antonia, David R. Spigel, Phillip A. Dennis, Corey J. Langer, Cathy O'Brien, David Planchard, Shuji Murakami, David Vicente, Anna Rydén, Y. Zhang, Marina Chiara Garassino, Suresh Senan, Rina Hui, Alex Spira

المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

المصدر: Future Oncology, 17(10), 1165-1184. Future Medicine Ltd.
Garassino, M C, Paz-Ares, L, Hui, R, Faivre-Finn, C, Spira, A, Planchard, D, Ozguroglu, M, Daniel, D, Vicente, D, Murakami, S, Langer, C, Senan, S, Spigel, D, Ryden, A, Zhang, Y, O'Brien, C, Dennis, P A & Antonia, S J 2021, ' Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer ', Future Oncology, vol. 17, no. 10, pp. 1165-1184 . https://doi.org/10.2217/fon-2020-1102Test
Garassino, M C, Paz-Ares, L, Hui, R, Faivre-Finn, C, Spira, A, Planchard, D, Özgüroğlu, M, Daniel, D, Vicente, D, Murakami, S, Langer, C, Senan, S, Spigel, D, Rydén, A, Zhang, Y, O'Brien, C, Dennis, P A & Antonia, S J 2021, ' Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer ', Future Oncology, vol. 17, no. 10, pp. 1165-1184 . https://doi.org/10.2217/fon-2020-1102Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Durvalumab, durvalumab, Population, Placebo, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Patient Reported Outcome Measures, 030212 general & internal medicine, Stage (cooking), Lung cancer, education, programmed cell death ligand-1, Immune Checkpoint Inhibitors, Neoplasm Staging, Retrospective Studies, education.field_of_study, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Antibodies, Monoclonal, General Medicine, medicine.disease, humanities, Stage III Non-Small Cell Lung Cancer, Clinical trial, Treatment Outcome, patient-reported outcomes, 030220 oncology & carcinogenesis, Female, business, Chemoradiotherapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8996710d39bff8fe354388b7492bdc5bTest
https://research.vumc.nl/en/publications/c03a6381-5105-41ae-bdc3-fef7664d188bTest

5

Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)

المؤلفون: Rina Hui, Scott J. Antonia, Catherine Wadsworth, Suresh Senan, Bradford A. Perez, David Vicente, Davey B. Daniel, A. Villegas, Luis Paz-Ares, David R. Spigel, Mustafa Ozguroglu, Shuji Murakami, Corinne Faivre-Finn, Phillip A. Dennis, Helen Broadhurst, Corey J. Langer

المساهمون: Radiation Oncology, CCA - Cancer Treatment and quality of life

المصدر: Faivre-Finn, C, Spigel, D R, Senan, S, Langer, C, Perez, B A, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-Ares, L, Broadhurst, H, Wadsworth, C, Dennis, P A & Antonia, S J 2021, ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ', Lung Cancer, vol. 151, pp. 30-38 . https://doi.org/10.1016/j.lungcan.2020.11.024Test
Lung Cancer, 151, 30-38. Elsevier Ireland Ltd
Faivre-finn, C, Spigel, D R, Senan, S, Langer, C, Perez, B A, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-ares, L, Broadhurst, H, Wadsworth, C, Dennis, P A & Antonia, S J 2020, ' Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) ', Lung Cancer . https://doi.org/10.1016/j.lungcan.2020.11.024Test

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Randomization, Durvalumab, Lung Neoplasms, Pd-L1 Expression, Docetaxel, Placebo, Vinorelbine, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Median follow-up, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Chemotherapy, Humans, Etoposide, Radiotherapy, business.industry, Antibodies, Monoclonal, Biomarker, Chemoradiotherapy, Concurrent, Carboplatin, Blockade, 030104 developmental biology, Nivolumab, Oncology, chemistry, 030220 oncology & carcinogenesis, Cell Lung-Cancer, Immunotherapy, Cisplatin, business, Non-small-cell lung cancer, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc66d1431e19641df7ad85c29d2fa5d3Test
https://research.vumc.nl/en/publications/a94e824c-5543-4cff-95c7-1dd8269a3f90Test

6

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)

المؤلفون: Phillip A. Dennis, Michael Newton, Shuji Murakami, A. Villegas, M. Vincent, Mark A. Socinski, Helen Mann, Rina Hui, Scott J. Antonia, Davey B. Daniel, Keunchil Park, David Vicente, Mustafa Ozguroglu, Jhanelle E. Gray

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Male, Cancer Research, medicine.medical_specialty, Durvalumab, Lung Neoplasms, Survival, Immune-checkpoint inhibitors, Placebo, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, In patient, Patient Reported Outcome Measures, Lung cancer, Adverse effect, Aged, Patient-reported outcomes, business.industry, Hazard ratio, Antibodies, Monoclonal, Chemoradiotherapy, medicine.disease, Stage III Non-Small Cell Lung Cancer, Concurrent chemoradiotherapy, Exploratory analysis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Safety, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76af519faebbedb9b884a946e8cbe4ffTest
https://hdl.handle.net/20.500.12831/6950Test

7

ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

المؤلفون: Kathryn Kolibaba, David Lorente Estelles, Craig Gedye, David Vicente, Carole Gourmelon, Mustafa Khasraw, David A. Reardon, Chee Lee, Michael Weller, Christoph Helwig, Macarena I. de la Fuente, Morris D. Groves, Laureen S. Ojalvo

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d60b6e9edd09e6617ca725207c79d7aTest
https://europepmc.org/articles/PMC6216129Test/

8

Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms

المؤلفون: Esteban Nogales Fernández, Juan Jose Reina Zoilo, Luis de la Cruz-Merino, Enrique Grande Pulido, Fernando Henao Carrasco, David Vicente Baz, Manuel Codes Manuel de Villena

المصدر: Clinical and Developmental Immunology, Vol 2011 (2011)
Clinical and Developmental Immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b5db6281a432254f72cd9f1fdb16faTest
https://doaj.org/article/f5a64aa4e97645fa901d4eb4934340bcTest

تنقيح النتائج